Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Veterinary Vertex

Veterinary Vertex artwork

Extralabel Rabies Vaccination: Serologic Response Across 28 Mammalian Species

Sep 12, 202617 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Send us Fan Mail A single bite or wildlife exposure can turn “vaccinated” into a complicated question fast, especially when the animal is a zoological species, a wildlife rehabilitation patient, or any non-traditional mammal that does not have a licensed rabies vaccine label. We sit down with Dr. Ryan Wallace, who leads the rabies program at the US Centers for Disease Control and Prevention, to unpack what clinicians and public health teams can lean on when the rules feel vague and the consequences are real. We walk through what the research shows about serologic response after extra-label rabies vaccination across many mammalian species, including how often animals reach protective antibody titers after a primary dose and where responses can be lower in very large species or very small species. Ryan also explains why antibody titers naturally decline over time, what “boostability” means in practical terms, and why a strong anamnestic response after a booster can be the signal decision-makers need when assessing risk after exposure. We also tackle the questions you hear in the exam room: “Why not just titer-check every animal?” and “Does my indoor cat really need rabies vaccination?” The answer involves cost, exposure recognition, and one word that changes everything for indoor pets: bats. If you work in zoo veterinary medicine, wildlife rehabilitation, shelter medicine, or small animal practice, this is a grounded look at evidence that may help prevent unnecessary euthanasia while protecting people and animals. Subscribe, share this with a colleague who fields rabies calls, and leave a review on Apple Podcasts or wherever you listen. JAVMA article: https://doi.org/10.2460/javma.26.04.0246 INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ®? JAVMA ®: https://avma.org/JAVMAAuthors AJVR ®: https://avma.org/AJVRAuthors FOLLOW US: JAVMA ®: Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ®: Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

Hill's Prescription DietEvery vet knows that cats love to get into trouble. But when your patients experience urinary issues, they need Hill's prescription diet CD multicare stress cat food. With therapeutic nutrition formulated to reduce the recurrence of FIC signs by 89%, dissolve struvite stones in as little as seven days, help manage stress and improve social engagement, your patients can get back to feeling good. And getting up to no good. Intended for veterinary professionals.

Lisa FortierWelcome to Epic Award-winning Veterinary Vertex, the AVMA Journal's podcast, where we delve into behind-the-scene look with manuscript authors. I'm editor-in-chief Lisa Fortier, joined by associate editor Sarah Wright. Today we're discussing the serological response to extra-label use of perennial rabies vaccine in mammalian species with our guest, Ryan Wallace. Thank you for joining us, Ryan.

Ryan WallaceThank you so much for inviting me back on the podcast. I'm happy to be here.

Lisa FortierYeah, it's great to have you back. Ryan, in this study, what prompted you to look at extra-labeled rabies vaccine across so many mammalian species? And what really are the practical problems that this off-label, off-label gap created for zoos, wildlife rehab, and zoological companion animal veterinarians?

Ryan WallaceYeah, so maybe first just uh a little bit about my background. I lead the rabies program at the U.S. Centers for Disease Control and Prevention. Um, we have two kind of critical roles that are related to this study. One is we oversee the National Rabies Reference Laboratory, uh, which is a network of over 130 uh academic, agriculture, and public health labs that offer animal rabies testing. And we'll say we have the world's most robust animal rabies surveillance system uh testing far more animals than anyone else in the world.

Ryan WallaceUh so our CDC program kind of oversees that network. And there were also the national rabies surveillance system. So uh rabies is a notifiable disease. And so when states do get reports of rabies in animals or people, uh that information is notified to us. And my group coordinates that and every every year publish an annual report in the Journal of American Veterinary Medical Association. Uh so kind of in that role that I have, I and a few other people on my team answer about 2,000 uh public inquiries a year related to rabies.

Ryan WallaceAnd I I only do rabies. So I think I'm one of the few people in the world that's like 40 hours a week, probably more, dedicated to rabies, answering rabies questions, doing rabies studies. Um and so about 2,000 times a year, a state out department, agriculture, John Q Public, they're reaching out and asking a rabies question. And a good chunk of those questions are what to do when an animal that is not one of our species that has a licensed rabies vaccine product either becomes exposed to rabies or bites a person and is now being assessed as potentially having rabies.

Ryan WallaceUm, we have excellent guidance in the NASPHB rabies compendium that hopefully all of our US veterinarians are well aware of. Uh, excellent guidance for what to do with a vaccinated dog, cat, ferret, sheep, you know, our common pets and livestock. The guidance for what to do when an animal has been vaccinated off label is very vague and case by case. Uh, so part of like the inspiration for this is because a big chunk of my time is spent dealing with these ad hoc uh situations, bespoke recommendations, the gray zone.

Ryan WallaceUh I, as part of my job, keep up with the rabies literature uh quite well, and uh for for years have felt quite confident that off-label, extra label vaccination does confer broad immunity in mammalian species. So uh oftentimes I am providing these papers or the recommendation to our state health departments that it is okay to observe this off-label vaccinated animal for a while, um, or treat them similar similarly to how you would treat a vaccinated daughter cat.

Ryan WallaceBut I have not had a very good citation to pump into. Uh one other thing was happening around, yeah. So that's been happening for years. Uh, we have not had that clear guidance, and we, you know, lots of people have asked for it. Uh some colleagues of mine who ended up being co-authors on this paper uh out of Germany had just completed an exhaustive literature search on uh lab animal studies on vaccinology of rabies. And I had the pleasure of reviewing that paper and saw that they had over a thousand research articles already identified and abstracted and sitting in a database ready to answer additional questions.

Ryan WallaceSo I reached out to them and said, Hey, do you think we could use that your your exhaustive literature search to also address this question about extra-level vaccination? And uh they said yes, and we were off to the races with this study. I think for your your second part of that question about the uh the practical problems, uh just I think I sort of alluded to it, but to be really clear, there are really there are two very real-world everyday issues that I hope this paper starts to provide clarity to.

Ryan WallaceOne is my non-dog cat, whatever mammal, um has just you know he he's vaccinated off label, but he's just been exposed to a rabid raccoon. What do I do? This should prov this study and the results we found should provide state public health authorities with some good evidence to feel confident that there are options other than euthanasia. If your animal is unvaccinated, euthanasia is probably the best option in those situations.

Ryan WallaceAnd then the second one, as I alluded to, my off-label vaccinated, you know, insert any of the 6,000 mammals that exist in the world, uh you know, has now bitten me or my neighbor. Do I need to euthanize that animal? And again, this study should provide a lot of confidence for options other than euthanasia. Uh I do have to caution though, until regulations change, you know, that this is all just scientific evidence to support public health decision making.

Sarah WrightYeah, really great practical information in this manuscript for our clinicians that see non-traditional species. Additionally, too, the rabies manuscripts that your group submits are always very highly performing in GAFMA, which is always appreciated too. It's very cool to see the attention that they receive and how many people are reading them and citing them as well. So they're also very impactful too in the scholarly community as well.

Ryan WallaceYeah, there's really no better as a veterinary epidemiologist, rabies is the absolute best field to be in. I mean, we we deal with you know the zoonotic aspect, it's purely the animal aspect when there's a human case we're involved. Um, but JAVMA is our go-to journal anytime we have these studies that were really targeting the US veterinary professionals.

Lisa FortierYeah, we really appreciate that. There's some of our most highly read and cited, as you probably know. Like it's obviously critical for our profession. Yeah, we're really happy to hear that.

Sarah WrightBack to your article. Over 84% of animals had protective antibody titers after primary vaccination. How did that compare to what you expected?

Ryan WallaceUm, so I like I said, I I do keep up with the literature. So all these piecemealed little studies that have come out over the last 20 years or so uh have largely all shown high serial conversion after primary vaccination. Um, these off-label species. So going in, I was quite confident we should see that off-label vaccination is comparable or at least very close to uh what we see for the licensed animals, primarily, and as as we chose here, dogs as the uh the gold standard comparison.

Ryan WallaceUm I I was a little a little surprised, not totally surprised, but a little surprised that we did see um significantly lower serial conversion rates in some of our larger mass species, notably elephants and bears. Uh and then we also saw lower stereo conversion rates in our tiny species, the bats. And I think there are um explanations for why that occurs. And I don't think it really casts doubt on the effectiveness of modern-day cell culture commercially available rabies vaccines.

Ryan WallaceUh, but for years we've known there is a bit of a dose body mass association with this vaccine.

Lisa FortierRyan, along with the uh protective antibody titers, uh, the titer persistence drop to under 64%, I think, uh, by six months. What's the practical implications of that drop in titer?

Ryan WallaceSo all vaccines display a pretty typical immunologic curve. So you you vaccinate, and hopefully within a few days, if it's a antigenically competent vaccine, your titer goes up. The goal of your immune response is to make those memory BNT cells. It's not to keep a high titer forever. The goal of, especially rabies vaccine is that when you're exposed in the future, those BNT memory cells can quickly proliferate and get a sky high antibody titer.

Ryan WallaceUh that is what protects animals, people you know, from from getting rabies. So it is expected that over months after, especially primary vaccination, titers will fall. Um the fact that 64% fell below, or we're at 64% uh you know, three, six, nine months afterwards, not very surprising. And with such a wide array of species and study designs, I also wasn't that surprised.

Ryan WallaceBut what I think the readers should draw their attention to is the boostability that was demonstrated in a subset of these studies, where I think it was something like 89 to 90 percent of animals that then got a second vaccine showed that amnestic response. And that is spot on with what we see with our licensed species, and that amnestic or booster response is what we uh look for to decide if an animal is likely to survive infection.

Lisa FortierI don't never heard that word boostability. I like that.

Ryan WallaceI might have just made it up here, I'm not sure.

Lisa FortierRyan, it always intrigued me personally that I was vaccinated in vet school in the 80s and then uh had my titers checked yearly, and my titers stayed within the recommended range. Why don't we do that in animals? I've never understood that.

Ryan WallaceSo the there are um different recommendations, well, especially in humans, there's different recommendations based on your risk of exposure to rabies virus. And so if you're in an occupation where you might be exposed to rabies and not recognize that that exposure has occurred, then we're concerned you're not going to go get that booster, mount that an amestic response and be protected. And for those occupations, we do rely, we do want to ensure that you have a continuously high circulating anti virus, uh, sorry, antibody titer.

Ryan WallaceUm, those are primarily our laboratory uh di our laboratory diagnosticians that are working with ravis virus on a daily basis. They get a little nick, they walk through the freezer and get scratched by a carcass that's in there, which these all happen. We get calls about this all the time. Um, they might not necessarily think they need to go get their booster vaccine, but they get these tighter checks and they are assured that they have high circulating. Also, it uh ensures for our people that if they do have a change in their immune system, that we're going to detect that relatively quickly and they can make their occupational decisions based on that information.

Ryan WallaceUm, in in animals, you know, if they're if they're well cared for, kept inside, or at least monitored by a responsible owner, they really shouldn't be having unrecognized rabies exposures. When those exposures happen, they can reliably get boosters. I'd say the other argument I would put against treating animals the way we treat people is just the cost. I mean, if anybody has had to pay for a titer for their animal, they're not cheap, especially compared to just getting your rabies booster.

Ryan WallaceUm, you know, it can a large population of animal owners opting for that titer route, the cost would be quite high.

Sarah WrightRyan, I have a question for you for just some people I've talked to before and trying to convince some that their indoor animals still need to be vaccinated for rabies. So if someone comes to you and they say, you know, my animal never goes outside, I don't understand how it would get rabies. I'm not going to vaccinate it. What would what do you say to those people?

Ryan WallaceBats. Bats love to live in our house. Bats are our number one rabies reservoir uh in the United States, and especially indoor cats, they are experts at catching bats. So um I think you can probably talk to any state public health veterinary, and they'll have dozens of examples of um rabid cats that largely stay indoors or the calls from concerned owners where they're found their cat chewing on a on a dead bat in their house. So um I that that to me is the number one risk uh for pets that largely stay indoors.

Ryan WallaceYou cannot guarantee that bats won't get into your house. Uh oftentimes people are very delayed in recognizing a colony has moved in. And usually your pet, especially a you know, a cat that's an expert at hunting these things, is the first indicator that a lot of homeowners get that they do have a bat problem in their house. Um I think though that's probably the best example of why. We can't control wildlife, and your pets are the front line of that wildlife interaction. We need to make sure that they are protected.

Ryan WallaceIf you don't care about yourself, you know, for your pet, make sure they at the front line of this are protected.

Lisa FortierYeah, I definitely had that experience where the cats were told us what was going on in the walls. Ryan, how should the um the results of this study might, how might they change quarantine exposure protocols for vaccinated non-domestic animals?

Ryan WallaceYeah. Um, I mean, we all, I think everybody, all the researchers, everybody writes papers for Jabma that's listening to this, uh, you know, I'm sure our hope is that our work eventually impacts how we operate as a veterinary community or through regulatory actions. Um other thing I didn't say earlier about the kind of impetus for the study, you know, not only had some colleagues of mine already curated this massive database uh that was perfect for implementing this study.

Ryan WallaceUm I and several of the co-authors are part of the NASPHB Rabies compendium, which is currently reviewing um reviewing the the national guidance to see where updates can be made. So uh another reason we were thinking, well, it's timely and we need to get this done quick is because we wanted this data synthesized and published so that we could consider it for updating the NAS PHP compendium national rabies guidance.

Ryan WallaceUh, I don't want to give away too much, and discussions are still ongoing, but I can say this this study and a few other pivotal studies that have come out in the last five to ten years are being uh considered for some pretty big updates to U.S. rabies guidance.

Sarah WrightWell, Ryan, thank you so much for joining us. It's been a pleasure chatting with you about rabies and learning more too about this really robust study as well. Yeah, thank you, Ryan.

Ryan WallaceThanks so much for having me.

Sarah WrightFor our listeners and viewers, you can read Ryan's article in JAVMA. I'm Sarah Wright with Lisa Fortier. Be sure to tune in next week for another episode of Veterinary Vertex. And don't forget to leave us a rating and review on Apple Podcasts or wherever you listen.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Beyond the Alcohol Swipe: Rapid Disinfection for Suture Scissors

    Nov 16, 202611 minAudio

    Send us Fan Mail A pair of suture scissors can feel like the definition of “low risk” until you look at what’s actually living on them between patients. We sit down with Kathryn P. Spivey, returning guest and AJVR...

    Credit the people on this episode

  2. Can a Nasal Vaccine Protect Calves From RSV?

    Nov 7, 202621 minAudio

    Send us Fan Mail A calf can look “fine” and still be losing ground in the lungs and that’s exactly why BRSV keeps costing farms money. We sit down with Dr. John Ellis to unpack a rare head-to-head comparison of two...

    Credit the people on this episode

  3. Gut Check: Why Oral Fecal Transplants Fell Short for Tylosin-Responsive Dogs

    Oct 30, 202618 minAudio

    Send us Fan Mail Dogs with chronic enteropathy can make even seasoned clinicians feel stuck: antibiotics help, symptoms fade, then everything flares the moment treatment stops. We sit down with Drs. Moshen Hanifeh and...

    Credit the people on this episode

  4. Hit or Miss: Antibiotic Delivery to Foal Joints

    Oct 23, 202617 minAudio

    Send us Fan Mail Septic arthritis in a neonatal foal is one of those diagnoses that can change everything fast: the foal’s comfort today, survival to discharge, and even long-term athletic soundness once cartilage gets...

    Credit the people on this episode

  5. Reading the Rhythm: How Cycle Length Variation Helps Diagnose Equine Arrhythmias

    Oct 17, 202616 minAudio

    Send us Fan Mail One strange beat on a resting horse ECG can spark a surprisingly high-stakes question: are we seeing a normal sinus arrhythmia, or an atrial premature complex that changes how we think about risk and...

    Credit the people on this episode